JP2016516805A5 - - Google Patents

Download PDF

Info

Publication number
JP2016516805A5
JP2016516805A5 JP2016508263A JP2016508263A JP2016516805A5 JP 2016516805 A5 JP2016516805 A5 JP 2016516805A5 JP 2016508263 A JP2016508263 A JP 2016508263A JP 2016508263 A JP2016508263 A JP 2016508263A JP 2016516805 A5 JP2016516805 A5 JP 2016516805A5
Authority
JP
Japan
Prior art keywords
oxo
pyrido
oxazolidine
ethyl
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016508263A
Other languages
English (en)
Japanese (ja)
Other versions
JP6375365B2 (ja
JP2016516805A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/060724 external-priority patent/WO2014170821A1/en
Publication of JP2016516805A publication Critical patent/JP2016516805A/ja
Publication of JP2016516805A5 publication Critical patent/JP2016516805A5/ja
Application granted granted Critical
Publication of JP6375365B2 publication Critical patent/JP6375365B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016508263A 2013-04-16 2014-04-15 抗菌活性を有する二芳香族誘導体 Expired - Fee Related JP6375365B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IBPCT/IB2013/053021 2013-04-16
IB2013053021 2013-04-16
PCT/IB2014/060724 WO2014170821A1 (en) 2013-04-16 2014-04-15 Antibacterial biaromatic derivatives

Publications (3)

Publication Number Publication Date
JP2016516805A JP2016516805A (ja) 2016-06-09
JP2016516805A5 true JP2016516805A5 (enExample) 2017-06-01
JP6375365B2 JP6375365B2 (ja) 2018-08-15

Family

ID=50639826

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016508263A Expired - Fee Related JP6375365B2 (ja) 2013-04-16 2014-04-15 抗菌活性を有する二芳香族誘導体

Country Status (21)

Country Link
US (1) US9527867B2 (enExample)
EP (1) EP2986607B1 (enExample)
JP (1) JP6375365B2 (enExample)
KR (1) KR20150143720A (enExample)
CN (1) CN105143216B (enExample)
AR (1) AR095884A1 (enExample)
AU (1) AU2014255326B2 (enExample)
BR (1) BR112015026261A8 (enExample)
CA (1) CA2907832A1 (enExample)
CL (1) CL2015003019A1 (enExample)
EA (1) EA029361B1 (enExample)
ES (1) ES2640482T3 (enExample)
HK (1) HK1221459A1 (enExample)
MA (1) MA38588B1 (enExample)
MX (1) MX362338B (enExample)
PH (1) PH12015502411A1 (enExample)
PL (1) PL2986607T3 (enExample)
SA (1) SA515361261B1 (enExample)
SG (1) SG11201508479RA (enExample)
TW (1) TWI631119B (enExample)
WO (1) WO2014170821A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104151316B (zh) 2008-10-07 2016-06-15 埃科特莱茵药品有限公司 三环噁唑烷酮抗生素化合物
AR102256A1 (es) * 2014-10-15 2017-02-15 Actelion Pharmaceuticals Ltd Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi
TW201722965A (zh) 2015-08-16 2017-07-01 葛蘭素史密斯克藍智慧財產發展有限公司 用於抗菌應用之化合物
TW201808906A (zh) 2016-03-16 2018-03-16 拜耳作物科學股份有限公司 作為殺蟲劑之經取代吡啶化合物
AR108108A1 (es) 2016-04-14 2018-07-18 Idorsia Pharmaceuticals Ltd Derivados biaromáticos antibacterianos con sustitución de oxetan-3-iloxi
GB2550437B (en) * 2016-05-20 2021-06-23 Bugworks Res Inc Heterocyclic compounds useful as anti-bacterial agents and method for production
TW201833120A (zh) * 2017-02-17 2018-09-16 瑞士商愛杜西亞製藥有限公司 芳基噁唑啶酮抗生素化合物
EP3284739A1 (de) 2017-07-19 2018-02-21 Bayer CropScience Aktiengesellschaft Substituierte (het)arylverbindungen als schädlingsbekämpfungsmittel
ES2952989T3 (es) * 2017-11-29 2023-11-07 Bugworks Res Inc Compuestos heterocíclicos antibacterianos y su síntesis
EP4474017A3 (en) 2018-08-13 2025-02-26 F. Hoffmann-La Roche AG New heterocyclic compounds
WO2021048242A1 (en) 2019-09-12 2021-03-18 F. Hoffmann-La Roche Ag 4,4a,5,7,8,8a-hexapyrido[4,3-b][1,4]oxazin-3-one compounds as magl inhibitors
EP4126855B1 (en) * 2020-03-24 2024-04-24 F. Hoffmann-La Roche AG Compounds and their use in the treatment of bacterial infections
CN115785718B (zh) * 2022-11-25 2023-08-22 四川大学 一种多基底表面的金属配位抗菌涂层及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0297042A1 (de) 1987-06-23 1988-12-28 Ciba-Geigy Ag Substituierte Penem-Verbindungen
DE19802239A1 (de) 1998-01-22 1999-07-29 Bayer Ag Neue mit Bicyclen substituierte Oxazolidinone
AU1026901A (en) 1999-10-29 2001-05-08 Syngenta Participations Ag Novel herbicides
WO2003043997A1 (en) 2001-11-15 2003-05-30 Eli Lilly And Company Peroxisome proliferator activated receptor alpha agonists
AR040335A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto
WO2006102674A2 (en) 2005-03-24 2006-09-28 Microbia, Inc. Diphenylheterocycle cholesterol absorption inhibitors
TW200734311A (en) 2005-11-21 2007-09-16 Astrazeneca Ab New compounds
US7998992B2 (en) 2007-03-30 2011-08-16 Institute Of Medicinal Molecular Design, Inc. Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1
CL2008001003A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
SG170779A1 (en) 2007-12-20 2011-05-30 Pharma Mar Sa Antitumoral compounds
AU2009215327A1 (en) 2008-02-20 2009-08-27 Actelion Pharmaceuticals Ltd Azatricyclic antibiotic compounds
AR070458A1 (es) 2008-02-22 2010-04-07 Actelion Pharmaceuticals Ltd Derivados de oxazolidina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de una infeccion bacteriana.
EP2321307B1 (en) * 2008-08-04 2012-12-19 Actelion Pharmaceuticals Ltd. Tricyclic alkylaminomethyloxazolidinone derivatives
CN104151316B (zh) 2008-10-07 2016-06-15 埃科特莱茵药品有限公司 三环噁唑烷酮抗生素化合物
JP2012505201A (ja) * 2008-10-10 2012-03-01 アクテリオン ファーマシューティカルズ リミテッド 2−ベンゾチオフェニル−及び2−ナフチル−オキサゾリジノン、並びにそれらのアザアイソスター(azaisostere)類似体
AR088691A1 (es) 2011-11-08 2014-06-25 Actelion Pharmaceuticals Ltd Derivados antibioticos de 2-oxo-oxazolidin-3,5-diilo

Similar Documents

Publication Publication Date Title
JP2016516805A5 (enExample)
RU2501799C2 (ru) Поизводные оксазолидинона
IL283539B1 (en) 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same
HRP20230143T1 (hr) Nove kemijske molekule koje inhibiraju mehanizam prekrajanja za liječenje bolesti koje su posljedica defekata prekrajanja
JP2015514794A5 (enExample)
US20150057271A1 (en) Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
JP2012522007A5 (enExample)
RU2012126083A (ru) Производные аминооксазина
JP2019528291A5 (enExample)
JP2013542937A5 (enExample)
TWI825079B (zh) 新穎的芳基或雜芳基三唑酮衍生物或其鹽或包含彼等之醫藥組合物
JP2016512558A5 (enExample)
RU2014108919A (ru) Хиназолин-2,4-дионовые производные
JP2014532626A5 (enExample)
JP2020503291A5 (enExample)
JP2014532754A5 (enExample)
RU2008116828A (ru) Комбинированный метод терапии замещенными оксазолидинонами для профилактики и лечения нарушений церебрального местного кровообращения
JP2018507234A5 (enExample)
JP2014523400A (ja) 芳香族アミド類およびそれらの使用
RU2014123109A (ru) Антибиотические производные 2-оксо-оксазолидин-3, 5-диила
JP2022025116A (ja) 抗菌性化合物
JP2020512401A5 (enExample)
RU2015128025A (ru) Ингибиторы сомт
JP2018508553A5 (enExample)
JP2020503293A5 (enExample)